180 related articles for article (PubMed ID: 37804316)
1. Sustained OMA1-mediated integrated stress response is beneficial for spastic ataxia type 5.
Franchino CA; Brughera M; Baderna V; De Ritis D; Rocco A; Seneca S; Regal L; Podini P; D'Antonio M; Toro C; Quattrini A; Scalais E; Maltecca F
Brain; 2024 Mar; 147(3):1043-1056. PubMed ID: 37804316
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial stress is relayed to the cytosol by an OMA1-DELE1-HRI pathway.
Guo X; Aviles G; Liu Y; Tian R; Unger BA; Lin YT; Wiita AP; Xu K; Correia MA; Kampmann M
Nature; 2020 Mar; 579(7799):427-432. PubMed ID: 32132707
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic variants in the AFG3L2 proteolytic domain cause SCA28 through haploinsufficiency and proteostatic stress-driven OMA1 activation.
Tulli S; Del Bondio A; Baderna V; Mazza D; Codazzi F; Pierson TM; Ambrosi A; Nolte D; Goizet C; Toro C; Baets J; Deconinck T; DeJonghe P; Mandich P; Casari G; Maltecca F
J Med Genet; 2019 Aug; 56(8):499-511. PubMed ID: 30910913
[TBL] [Abstract][Full Text] [Related]
4. A novel AFG3L2 mutation close to AAA domain leads to aberrant OMA1 and OPA1 processing in a family with optic atrophy.
Baderna V; Schultz J; Kearns LS; Fahey M; Thompson BA; Ruddle JB; Huq A; Maltecca F
Acta Neuropathol Commun; 2020 Jun; 8(1):93. PubMed ID: 32600459
[TBL] [Abstract][Full Text] [Related]
5. Spinocerebellar Ataxia Type 28-Phenotypic and Molecular Characterization of a Family with Heterozygous and Compound-Heterozygous Mutations in AFG3L2.
Tunc S; Dulovic-Mahlow M; Baumann H; Baaske MK; Jahn M; Junker J; Münchau A; Brüggemann N; Lohmann K
Cerebellum; 2019 Aug; 18(4):817-822. PubMed ID: 31111429
[TBL] [Abstract][Full Text] [Related]
6. Expanding the phenotype of AFG3L2 mutations: Late-onset autosomal recessive spinocerebellar ataxia.
Chiang HL; Fuh JL; Tsai YS; Soong BW; Liao YC; Lee YC
J Neurol Sci; 2021 Sep; 428():117600. PubMed ID: 34333379
[TBL] [Abstract][Full Text] [Related]
7. Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases.
Pierson TM; Adams D; Bonn F; Martinelli P; Cherukuri PF; Teer JK; Hansen NF; Cruz P; Mullikin For The Nisc Comparative Sequencing Program JC; Blakesley RW; Golas G; Kwan J; Sandler A; Fuentes Fajardo K; Markello T; Tifft C; Blackstone C; Rugarli EI; Langer T; Gahl WA; Toro C
PLoS Genet; 2011 Oct; 7(10):e1002325. PubMed ID: 22022284
[TBL] [Abstract][Full Text] [Related]
8. A pathway coordinated by DELE1 relays mitochondrial stress to the cytosol.
Fessler E; Eckl EM; Schmitt S; Mancilla IA; Meyer-Bender MF; Hanf M; Philippou-Massier J; Krebs S; Zischka H; Jae LT
Nature; 2020 Mar; 579(7799):433-437. PubMed ID: 32132706
[TBL] [Abstract][Full Text] [Related]
9. Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.
Mancini C; Hoxha E; Iommarini L; Brussino A; Richter U; Montarolo F; Cagnoli C; Parolisi R; Gondor Morosini DI; Nicolò V; Maltecca F; Muratori L; Ronchi G; Geuna S; Arnaboldi F; Donetti E; Giorgio E; Cavalieri S; Di Gregorio E; Pozzi E; Ferrero M; Riberi E; Casari G; Altruda F; Turco E; Gasparre G; Battersby BJ; Porcelli AM; Ferrero E; Brusco A; Tempia F
Neurobiol Dis; 2019 Apr; 124():14-28. PubMed ID: 30389403
[TBL] [Abstract][Full Text] [Related]
10. Targeting Aggressive B-cell Lymphomas through Pharmacological Activation of the Mitochondrial Protease OMA1.
Schwarzer A; Oliveira M; Kleppa MJ; Slattery SD; Anantha A; Cooper A; Hannink M; Schambach A; Dörrie A; Kotlyarov A; Gaestel M; Hembrough T; Levine J; Luther M; Stocum M; Stiles L; Weinstock DM; Liesa M; Kostura MJ
Mol Cancer Ther; 2023 Nov; 22(11):1290-1303. PubMed ID: 37643767
[TBL] [Abstract][Full Text] [Related]
11. OMA1-mediated integrated stress response protects against ferroptosis in mitochondrial cardiomyopathy.
Ahola S; Rivera Mejías P; Hermans S; Chandragiri S; Giavalisco P; Nolte H; Langer T
Cell Metab; 2022 Nov; 34(11):1875-1891.e7. PubMed ID: 36113464
[TBL] [Abstract][Full Text] [Related]
12. Concurrent AFG3L2 and SPG7 mutations associated with syndromic parkinsonism and optic atrophy with aberrant OPA1 processing and mitochondrial network fragmentation.
Magri S; Fracasso V; Plumari M; Alfei E; Ghezzi D; Gellera C; Rusmini P; Poletti A; Di Bella D; Elia AE; Pantaleoni C; Taroni F
Hum Mutat; 2018 Dec; 39(12):2060-2071. PubMed ID: 30252181
[TBL] [Abstract][Full Text] [Related]
13. The Mitochondrial PHB2/OMA1/DELE1 Pathway Cooperates with Endoplasmic Reticulum Stress to Facilitate the Response to Chemotherapeutics in Ovarian Cancer.
Cheng M; Yu H; Kong Q; Wang B; Shen L; Dong D; Sun L
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163244
[TBL] [Abstract][Full Text] [Related]
14. AFG3L2 supports mitochondrial protein synthesis and Purkinje cell survival.
Almajan ER; Richter R; Paeger L; Martinelli P; Barth E; Decker T; Larsson NG; Kloppenburg P; Langer T; Rugarli EI
J Clin Invest; 2012 Nov; 122(11):4048-58. PubMed ID: 23041622
[TBL] [Abstract][Full Text] [Related]
15. AFG3L2 Biallelic Mutation: Clinical Heterogeneity in Two Italian Patients.
Colucci F; Neri M; Fortunato F; Ferlini A; Carrozzo R; Torraco A; Lamantea E; Legati A; Tecilla G; Pugliatti M; Sensi M
Cerebellum; 2023 Dec; 22(6):1313-1319. PubMed ID: 36447112
[TBL] [Abstract][Full Text] [Related]
16. Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects.
Seong E; Insolera R; Dulovic M; Kamsteeg EJ; Trinh J; Brüggemann N; Sandford E; Li S; Ozel AB; Li JZ; Jewett T; Kievit AJA; Münchau A; Shakkottai V; Klein C; Collins CA; Lohmann K; van de Warrenburg BP; Burmeister M
Ann Neurol; 2018 Jun; 83(6):1075-1088. PubMed ID: 29604224
[TBL] [Abstract][Full Text] [Related]
17. Haploinsufficiency of AFG3L2, the gene responsible for spinocerebellar ataxia type 28, causes mitochondria-mediated Purkinje cell dark degeneration.
Maltecca F; Magnoni R; Cerri F; Cox GA; Quattrini A; Casari G
J Neurosci; 2009 Jul; 29(29):9244-54. PubMed ID: 19625515
[TBL] [Abstract][Full Text] [Related]
18. A mitochondrial iron-responsive pathway regulated by DELE1.
Sekine Y; Houston R; Eckl EM; Fessler E; Narendra DP; Jae LT; Sekine S
Mol Cell; 2023 Jun; 83(12):2059-2076.e6. PubMed ID: 37327776
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic activation of a compensatory integrated stress response kinase promotes mitochondrial remodeling in PERK-deficient cells.
Perea V; Baron KR; Dolina V; Aviles G; Kim G; Rosarda JD; Guo X; Kampmann M; Wiseman RL
Cell Chem Biol; 2023 Dec; 30(12):1571-1584.e5. PubMed ID: 37922906
[TBL] [Abstract][Full Text] [Related]
20. DELE1 oligomerization promotes integrated stress response activation.
Yang J; Baron KR; Pride DE; Schneemann A; Guo X; Chen W; Song AS; Aviles G; Kampmann M; Wiseman RL; Lander GC
Nat Struct Mol Biol; 2023 Sep; 30(9):1295-1302. PubMed ID: 37550454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
